Evidence map›Paper›PMID 40952767›Full record

ArticleChemSusChem2025

Electrochemical and Photoredox Catalysis for Constructing 5,5-Spirocycles via Reductive Activation of N-alkoxyphthalimides for the Total Synthesis of (-)-Cephalosporolide F.

Julio Romero-Ibañez, Karen A Guarneros-Cruz, Fernando Sartillo-Piscil, Bernardo Antonio Frontana-Uribe

Abstract read
In one paragraph

Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Julio Romero-IbañezDepartamento de Química Orgánica, Centro Conjunto de Investigación en Química Sustentable UAEMex-UNAM, Km. 14.5 Carretera Toluca-Atlacomulco, Toluca, C.P. 50200, Estado de México, México.ORCID https://orcid.org/0000-0001-9447-8344
Karen A Guarneros-CruzFacultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla., 72570, Puebla, México.
Fernando Sartillo-PiscilFacultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla., 72570, Puebla, México.ORCID https://orcid.org/0000-0002-4322-7534
Bernardo Antonio Frontana-UribeDepartamento de Química Orgánica, Centro Conjunto de Investigación en Química Sustentable UAEMex-UNAM, Km. 14.5 Carretera Toluca-Atlacomulco, Toluca, C.P. 50200, Estado de México, México.ORCID https://orcid.org/0000-0003-3796-5933

Funding

CONAHCYT A1-S-18230
6 · The paper itself

Abstract

The electrosynthetic (ES) approach employing rapid alternating polarity electrolysis and blue LED photoredox catalysis (PRC) is revised and compared in the synthesis of [5,5]-spiroketals through a tandem reductive activation of N-alkoxyphthalimides to alkoxy radical, followed by hydrogen atom transfer, and spirocyclization sequence. The role of leaving group and redox conditions is explored in the electrochemical transformation, revealing that diphenylphosphate-derived substrates exhibit superior performance. Both methodologies enable the stereoselective synthesis of (-)-Cephalosporolide F from the chiral pool, with a slightly higher yield for the PRC involving an iridium catalyst. This study showcases the potential use of electrochemical and photochemical green redox methodologies for radical-mediated transformations and late-stage synthesis of natural products, avoiding toxic stannyl reagents and bypassing expensive metal-based catalysts. These findings support the development of more sustainable synthetic strategies for complex natural products while acknowledging the use of CH

Indexed as

green chemistryN ‐alkoxyphthalimidesorganic electrosynthesisphotocatalysisspirocyclization

Identifiers

PMID40952767
PMCPMC12548939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.